학술논문
The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer
Document Type
Article
Author
Source
In Annals of Oncology June 2022 33(6):593-601
Subject
Language
ISSN
0923-7534